Philip L. Hodges's most recent trade in Altimmune Inc was a trade of 48,800 Stock Options (option to buy) done . Disclosure was reported to the exchange on Sept. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | Philip L. Hodges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 48,800 | 48,800 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Philip L. Hodges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 34,900 | 34,900 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Philip L. Hodges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2023 | 26,100 | 26,100 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Philip L. Hodges | Director | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 01 Mar 2021 | 6,000 | 8,731 (0%) | 0% | 16.1 | 96,480 | Common Stock, par value $0.0001 |